NCT01438814View on ClinicalTrials.gov

Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control

PHASE4CompletedINTERVENTIONAL
Enrollment

689

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

metformin placebo

metformin placebo tablets 500mg

DRUG

linagliptin placebo

linagliptin placebo tablets 5mg

DRUG

metformin

metformin tablets 500mg

DRUG

metformin

metformin tablets 500 mg

DRUG

linagliptin

linagliptin tablets 5mg

Trial Locations (90)

Unknown

1218.60.90001 Boehringer Ingelheim Investigational Site, Dhaka

1218.60.90002 Boehringer Ingelheim Investigational Site, Dhaka

1218.60.90003 Boehringer Ingelheim Investigational Site, Dhaka

1218.60.32001 Boehringer Ingelheim Investigational Site, Genk

1218.60.32005 Boehringer Ingelheim Investigational Site, Ham

1218.60.32002 Boehringer Ingelheim Investigational Site, Hasselt

1218.60.32004 Boehringer Ingelheim Investigational Site, Natoye

1218.60.32003 Boehringer Ingelheim Investigational Site, Tremelo

1218.60.20009 Boehringer Ingelheim Investigational Site, Calgary

1218.60.20003 Boehringer Ingelheim Investigational Site, Burnaby

1218.60.20014 Boehringer Ingelheim Investigational Site, Coquitlam

1218.60.20010 Boehringer Ingelheim Investigational Site, Surrey

1218.60.20004 Boehringer Ingelheim Investigational Site, Halifax

1218.60.20012 Boehringer Ingelheim Investigational Site, Corunna

1218.60.20015 Boehringer Ingelheim Investigational Site, Hamilton

1218.60.20006 Boehringer Ingelheim Investigational Site, London

1218.60.20013 Boehringer Ingelheim Investigational Site, London

1218.60.20002 Boehringer Ingelheim Investigational Site, Sarnia

1218.60.20011 Boehringer Ingelheim Investigational Site, Sarnia

1218.60.20005 Boehringer Ingelheim Investigational Site, Strathroy

1218.60.20007 Boehringer Ingelheim Investigational Site, Toronto

1218.60.20016 Boehringer Ingelheim Investigational Site, Toronto

1218.60.20001 Boehringer Ingelheim Investigational Site, Saint Romuald

1218.60.86001 Boehringer Ingelheim Investigational Site, Beijing

1218.60.86003 Boehringer Ingelheim Investigational Site, Beijing

1218.60.86011 Boehringer Ingelheim Investigational Site, Changsha

1218.60.86012 Boehringer Ingelheim Investigational Site, Chengdu

1218.60.86010 Boehringer Ingelheim Investigational Site, Chongqing

1218.60.86013 Boehringer Ingelheim Investigational Site, Hubei

1218.60.86014 Boehringer Ingelheim Investigational Site, Hubei

1218.60.86006 Boehringer Ingelheim Investigational Site, Nanjing

1218.60.86007 Boehringer Ingelheim Investigational Site, Nanjing

1218.60.86005 Boehringer Ingelheim Investigational Site, Shanghai

1218.60.86009 Boehringer Ingelheim Investigational Site, Shenyang

1218.60.86008 Boehringer Ingelheim Investigational Site, Wuxi

1218.60.49007 Boehringer Ingelheim Investigational Site, Berlin

1218.60.49008 Boehringer Ingelheim Investigational Site, Berlin

1218.60.49005 Boehringer Ingelheim Investigational Site, Dresden

1218.60.49004 Boehringer Ingelheim Investigational Site, Erfurt

1218.60.49006 Boehringer Ingelheim Investigational Site, Frankfurt

1218.60.49003 Boehringer Ingelheim Investigational Site, Hamburg

1218.60.49002 Boehringer Ingelheim Investigational Site, Neuwied

1218.60.49001 Boehringer Ingelheim Investigational Site, Unterschneidheim

1218.60.50001 Boehringer Ingelheim Investigational Site, Guatemala City

1218.60.50002 Boehringer Ingelheim Investigational Site, Guatemala City

1218.60.50003 Boehringer Ingelheim Investigational Site, Guatemala City

1218.60.85001 Boehringer Ingelheim Investigational Site, Hong Kong

1218.60.85002 Boehringer Ingelheim Investigational Site, Hong Kong

1218.60.91004 Boehringer Ingelheim Investigational Site, Aurangabad

1218.60.91010 Boehringer Ingelheim Investigational Site, Bangalore

1218.60.91005 Boehringer Ingelheim Investigational Site, Coimbatore

1218.60.91008 Boehringer Ingelheim Investigational Site, Kolkata

1218.60.91001 Boehringer Ingelheim Investigational Site, Nagpur

1218.60.91007 Boehringer Ingelheim Investigational Site, Nagpur

1218.60.91003 Boehringer Ingelheim Investigational Site, Pune

1218.60.91006 Boehringer Ingelheim Investigational Site, Pune

1218.60.96001 Boehringer Ingelheim Investigational Site, Beirut

1218.60.96002 Boehringer Ingelheim Investigational Site, Beirut

1218.60.96004 Boehringer Ingelheim Investigational Site, Byblos

1218.60.96003 Boehringer Ingelheim Investigational Site, Hazmiyeh

1218.60.96005 Boehringer Ingelheim Investigational Site, Saida

1218.60.52005 Boehringer Ingelheim Investigational Site, Aguascalientes

1218.60.52003 Boehringer Ingelheim Investigational Site, Cuernavaca

1218.60.52001 Boehringer Ingelheim Investigational Site, Durango

1218.60.52002 Boehringer Ingelheim Investigational Site, Durango

1218.60.52004 Boehringer Ingelheim Investigational Site, Monterrey

1218.60.51001 Boehringer Ingelheim Investigational Site, Lima

1218.60.51002 Boehringer Ingelheim Investigational Site, Lima

1218.60.51004 Boehringer Ingelheim Investigational Site, Piura

1218.60.63001 Boehringer Ingelheim Investigational Site, Cebu City, Philippines

1218.60.63004 Boehringer Ingelheim Investigational Site, Iloilo City, Philippines

1218.60.63003 Boehringer Ingelheim Investigational Site, Manila

1218.60.63002 Boehringer Ingelheim Investigational Site, Marikina City, Philippines

1218.60.63005 Boehringer Ingelheim Investigational Site, Quezon City

1218.60.34001 Boehringer Ingelheim Investigational Site, Barcelona

1218.60.34002 Boehringer Ingelheim Investigational Site, Barcelona

1218.60.34003 Boehringer Ingelheim Investigational Site, Barcelona

1218.60.34004 Boehringer Ingelheim Investigational Site, Barcelona

1218.60.34006 Boehringer Ingelheim Investigational Site, Borges Del Camp- Tarragona

1218.60.34005 Boehringer Ingelheim Investigational Site, Centelles

1218.60.34009 Boehringer Ingelheim Investigational Site, Granada

1218.60.34008 Boehringer Ingelheim Investigational Site, L'Hospitalet de Llobregat

1218.60.34007 Boehringer Ingelheim Investigational Site, Mataró

1218.60.34010 Boehringer Ingelheim Investigational Site, Valencia

1218.60.88006 Boehringer Ingelheim Investigational Site, Chiayi County

1218.60.88003 Boehringer Ingelheim Investigational Site, Kaohsiung City

1218.60.88001 Boehringer Ingelheim Investigational Site, Taichung

1218.60.88007 Boehringer Ingelheim Investigational Site, Taichung

1218.60.88002 Boehringer Ingelheim Investigational Site, Tainan City

1218.60.88004 Boehringer Ingelheim Investigational Site, Taipei County

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY